Integrated BioPharma, Inc.
INBP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $123 | -$178 | $611 | $116 |
| Dep. & Amort. | $250 | $327 | $304 | $318 |
| Deferred Tax | $68 | $772 | $244 | $51 |
| Stock-Based Comp. | $49 | $0 | $45 | $43 |
| Change in WC | $0 | -$412 | -$557 | $175 |
| Other Non-Cash | $811 | $82 | -$31 | -$502 |
| Operating Cash Flow | $1,301 | $591 | $616 | $201 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$173 | -$4 | -$116 | -$29 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$173 | -$4 | -$116 | -$29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | $0 | $0 |
| Stock Issued | $0 | $68 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$11 | $0 | $0 | $18 |
| Financing Cash Flow | -$11 | $67 | $0 | $18 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,117 | $654 | $500 | $190 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,615 | $2,961 | $2,461 | $2,271 |
| End Cash | $4,732 | $3,615 | $2,961 | $2,461 |
| Free Cash Flow | $1,128 | $587 | $500 | $172 |